Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.

Gynecologic oncology - 1 Nov 2021

Somasegar Sahana, Hoppenot Claire, Kuchta Kristine, Sereika Annette, Khandekar Janardan, Rodriguez Gustavo, Moore Elena, Hurteau Jean, Vogel Tilley Jenkins

Abstract excerpt

OBJECTIVE: Molecular tumor profiling and next-generation sequencing are being increasingly utilized, but there are limited data on the therapeutic implications and potential benefits of targeted treatments. We aim to characterize gynecologic oncology patients referred for somatic tumor genetic mutation testing and assess survival outcomes, efficacy, and toxicities of those receiving targeted therapy. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Genital Neoplasms, Female

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Targeted Therapy

Share to Neutropenia

Share to Precision Medicine

Share to Progression-Free Survival

Share to Thrombocytopenia

Source

Identifiers

PMID: 34511240
DOI: 10.1016/j.ygyno.2021.08.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.PMID 34511240Read ↗

The Utility of Next-Generation Sequencing in Advanced Breast and Gynecologic Cancers.Semantic proximity Read ↗

Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing PanelSemantic proximity Read ↗

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.Semantic proximity Read ↗

The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in OncologySemantic proximity Read ↗

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients.Semantic proximity Read ↗

Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.Semantic proximity Read ↗

Landscape of somatic mutated genes and inherited susceptibility genes in gynecological cancer.Semantic proximity Read ↗

Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancerSemantic proximity Read ↗

Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohort.Semantic proximity Read ↗

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability.Semantic proximity Read ↗

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsSemantic proximity Read ↗

Role of Genetics in Gynecologic Malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.